HIMS stock falls 4% on Amazon GLP-1 program launch

Hims & Hers (HIMS) stock fell 4%, snapping a six-session winning streak, as Amazon launched a rival GLP-1 program via One Medical. Amazon offers Wegovy and Foundayo with same-day delivery starting at $25. This new competition pressures HIMS, which recently expanded its own weight-loss offerings after settling a patent lawsuit with Novo Nordisk.